Scientists test if brain tumor drug gets where it needs to go
NCT ID NCT04424966
Summary
This early study aimed to see if an oral drug called infigratinib could reach brain tumors in patients with a specific genetic change. A small group of adults with recurrent high-grade glioma took the drug before their scheduled tumor removal surgery. Researchers then measured how much of the drug was present in the tumor tissue, blood, and spinal fluid collected during the operation to understand if it penetrates the brain effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chandler Regional Medical Center
Chandler, Arizona, 85224, United States
-
HonorHealth Scottsdale Osborn Medical Center
Scottsdale, Arizona, 85251, United States
-
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013, United States
Conditions
Explore the condition pages connected to this study.